These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 28043135
1. Screening Immunomodulators To Skew the Antigen-Specific Autoimmune Response. Northrup L, Sullivan BP, Hartwell BL, Garza A, Berkland C. Mol Pharm; 2017 Jan 03; 14(1):66-80. PubMed ID: 28043135 [Abstract] [Full Text] [Related]
2. Effects of immunomodulators on the response induced by vaccines against autoimmune diseases. Marciani DJ. Autoimmunity; 2017 Nov 03; 50(7):393-402. PubMed ID: 28906131 [Abstract] [Full Text] [Related]
3. Tolerogenic Nanoparticles Induce Antigen-Specific Regulatory T Cells and Provide Therapeutic Efficacy and Transferrable Tolerance against Experimental Autoimmune Encephalomyelitis. LaMothe RA, Kolte PN, Vo T, Ferrari JD, Gelsinger TC, Wong J, Chan VT, Ahmed S, Srinivasan A, Deitemeyer P, Maldonado RA, Kishimoto TK. Front Immunol; 2018 Nov 03; 9():281. PubMed ID: 29552007 [Abstract] [Full Text] [Related]
4. Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis. Kleist C, Mohr E, Gaikwad S, Dittmar L, Kuerten S, Platten M, Mier W, Schmitt M, Opelz G, Terness P. J Transl Med; 2016 May 01; 14(1):99. PubMed ID: 27131971 [Abstract] [Full Text] [Related]
16. B cell recognition of myelin oligodendrocyte glycoprotein autoantigen depends on immunization with protein rather than short peptide, while B cell invasion of the CNS in autoimmunity does not. Dang AK, Jain RW, Craig HC, Kerfoot SM. J Neuroimmunol; 2015 Jan 15; 278():73-84. PubMed ID: 25595255 [Abstract] [Full Text] [Related]